NCT05736120

Brief Summary

The purpose of this study is to understand the personal flow along the weight loss management journey. A range of variables will be addressed in a survey to explore the weight loss journey, barriers and management. Topics include weight loss strategies and challenges, HCP involvement, and perceptions towards weight loss medications. Potential participants will be recruited using various online panels. Study participants will be recruited to participate in 2 types of qualitative research. Phase I: Online bulletin boards (OBB) Phase II: Virtual focus groups (real-time)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

February 19, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2023

Completed
Last Updated

May 12, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

February 9, 2023

Last Update Submit

May 11, 2023

Conditions

Obesity

Outcome Measures

Primary Outcomes (4)

  • Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity.

    120-minute OBB discussion with numeric and open-ended response (Phase 1)

    5 days (Phase 1)

  • Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity.

    90-minute focus group with open-ended response (Phase 2)

    1 day (Phase 2)

  • Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey.

    120-minute OBB discussion with numeric and open-ended response (Phase 1)

    5 days (Phase 1)

  • Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey.

    90-minute focus group with open-ended response (Phase 2)

    1 day (Phase 2)

Study Arms (2)

Phase I

Online bulletin boards (OBB)

Other: No treatment given

Phase II

Virtual focus groups (real-time)

Other: No treatment given

Interventions

No treatment givenOTHER

No treatment given

Phase IPhase II

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will be recruited to participate in 2 types of qualitative research. Online Bulletin Boards and Virtual Focus Groups

You may qualify if:

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal to 18 years at the time of signing informed consent.
  • Current body mass index (BMI) of 25 or greater
  • Not currently pregnant
  • Does not participate in intense fitness or body building program
  • Weight loss not through illness or injury
  • At least somewhat concerned about current weight
  • If no plans for weight loss in the next six months, has made at least 1 weight loss effort in last 5 years
  • Struggling with weight for at least 3 years

You may not qualify if:

  • Previous participation in this study. Participation is defined as having given informed consent in this study
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Novo Nordisk Investigational Site

Bengaluru, India

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Clinical Transparency (dept. 2834)

    Novo Nordisk A/S

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2023

First Posted

February 21, 2023

Study Start

February 19, 2023

Primary Completion

April 19, 2023

Study Completion

April 19, 2023

Last Updated

May 12, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

"According to the Novo Nordisk disclosure commitment on novonordisk-trials.com"

More information

Locations

IN(1)